Manufacturing BMS banks on Texas for $2.3bn multi-modal manufacturing facility Pharmaceutical TechnologyThis will establish BMS' in-house manufacturing presence in Texas, adding to its ongoing outlicensing and research partnerships in the state.Read full story pharminent August 11, 2026 (Last updated: August 11, 2026) Pharmaceutical Technology This will establish BMS’ in-house manufacturing presence in Texas, adding to its ongoing outlicensing and research partnerships in the state. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfrontNext: Chasing Dupixent, a biotech aims to make better antibody drugs for eczema Related Stories Manufacturing AsymBio to secure $184m to support growth in biologics manufacturing pharminent August 5, 2026 Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026 Manufacturing GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy pharminent July 29, 2026
